Loading...
Harrow Health, Inc.
HROW•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$36.19
$-1.05(-2.81%)
Harrow Health, Inc. (HROW) Financial Performance & Income Statement Overview
Review Harrow Health, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
53.32%
↑ 53.32%
Operating Income Growth
1946.87%
↑ 1946.87%
Net Income Growth
28.39%
↑ 28.39%
Operating Cash Flow Growth
-678.18%
↓ 678.18%
Operating Margin
2.12%
↑ 2.12%
Gross Margin
74.53%
↑ 74.53%
Net Profit Margin
-10.19%
↓ 10.19%
ROE
-35.77%
↓ 35.77%
ROIC
2.55%
↑ 2.55%
Harrow Health, Inc. (HROW) Income Statement & Financial Overview
Review Harrow Health, Inc.'s (HROW) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $66.83M | $49.26M | $48.94M | $34.59M |
| Cost of Revenue | $14.13M | $12.02M | $12.54M | $10.55M |
| Gross Profit | $52.70M | $37.24M | $36.40M | $24.03M |
| Gross Profit Ratio | $0.79 | $0.76 | $0.74 | $0.69 |
| R&D Expenses | $4.75M | $2.27M | $3.05M | $2.15M |
| SG&A Expenses | $34.79M | $33.65M | $31.82M | $28.81M |
| Operating Expenses | $39.80M | $35.92M | $34.87M | $30.96M |
| Total Costs & Expenses | $53.68M | $47.94M | $47.41M | $41.52M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $6.38M | $5.53M | $5.47M | $5.42M |
| Depreciation & Amortization | $4.81M | $3.35M | $3.20M | $3.18M |
| EBITDA | $17.45M | $4.67M | $2.85M | -$4.97M |
| EBITDA Ratio | $0.26 | $0.09 | $0.06 | -$0.14 |
| Operating Income | $12.90M | $1.32M | $1.53M | -$6.93M |
| Operating Income Ratio | $0.19 | $0.03 | $0.03 | -$0.20 |
| Other Income/Expenses (Net) | -$5.61M | -$5.52M | -$7.35M | -$6.64M |
| Income Before Tax | $7.29M | -$4.20M | -$5.82M | -$13.56M |
| Income Before Tax Ratio | $0.11 | -$0.09 | -$0.12 | -$0.39 |
| Income Tax Expense | $514000.00 | $20000.00 | $655000.00 | $3.14M |
| Net Income | $6.78M | -$4.22M | -$6.47M | -$13.56M |
| Net Income Ratio | $0.10 | -$0.09 | -$0.13 | -$0.39 |
| EPS | $0.19 | -$0.12 | -$0.18 | -$0.38 |
| Diluted EPS | $0.19 | -$0.12 | -$0.18 | -$0.38 |
| Weighted Avg Shares Outstanding | $35.81M | $35.70M | $35.62M | $35.47M |
| Weighted Avg Shares Outstanding (Diluted) | $35.81M | $35.70M | $35.62M | $35.47M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan